|
Other Stroke Treatment - Medical
Citations 41-50 of 1103 total displayed.
|
Past content
(since Jan 1999):
|
- Original Contributions
Randomized, Placebo-Controlled, Double-Blind Study of Ropinirole in Chronic Stroke
- Steven C. Cramer, Bruce H. Dobkin, Elizabeth A. Noser, Rachelle W. Rodriguez, and Lori A. Enney
Stroke 2009;40:3034-3038; published online before print as doi:10.1161/STROKEAHA.109.552075
[Abstract]
[Full text]
- Original Contributions
Red Blood Cell Transfusion Increases Cerebral Oxygen Delivery in Anemic Patients With Subarachnoid Hemorrhage
- Rajat Dhar, Allyson R. Zazulia, Tom O. Videen, Gregory J. Zipfel, Colin P. Derdeyn, and Michael N. Diringer
Stroke 2009;40:3039-3044; published online before print as doi:10.1161/STROKEAHA.109.556159
[Abstract]
[Full text]
- Original Contributions
Effect of Hyperthermia on Prognosis After Acute Ischemic Stroke • Supplemental References
- Monica Saini, Maher Saqqur, Anmmd Kamruzzaman, Kennedy R. Lees, Ashfaq Shuaib on behalf of the VISTA Investigators
Stroke 2009;40:3051-3059; published online before print as doi:10.1161/STROKEAHA.109.556134
[Abstract]
[Full text]
- Original Contributions
Mast Cells Are Early Responders After Hypoxia-Ischemia in Immature Rat Brain
- Yuxuan Jin, Ann J. Silverman, and Susan J. Vannucci
Stroke 2009;40:3107-3112; published online before print as doi:10.1161/STROKEAHA.109.549691
[Abstract]
[Full text]
- Topical Review
Mitochondrial Targets for Stroke: Focusing Basic Science Research Toward Development of Clinically Translatable Therapeutics
- Peter S. Vosler, Steven H. Graham, Lawrence R. Wechsler, and Jun Chen
Stroke 2009;40:3149-3155; published online before print as doi:10.1161/STROKEAHA.108.543769
[Abstract]
[Full text]
- Controversies in Stroke
Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: Yes
- Daniel G. Hackam
Stroke 2009;40:3159-3160; published online before print as doi:10.1161/STROKEAHA.109.559054
[Full text]
- Controversies in Stroke
Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings: No
- Martin H. Strauss and Alistair Hall
Stroke 2009;40:3161-3162; published online before print as doi:10.1161/STROKEAHA.109.559062
[Full text]
- Articles
Age Disparities in Stroke Quality of Care and Delivery of Health Services
- Gustavo Saposnik, Sandra E. Black, Antoine Hakim, Jiming Fang, Jack Tu, Moira K. Kapral on behalf of the Investigators of the Registry of the Canadian Stroke Network (RCSN) and the Stroke Outcomes Research Canada (SORCan) Working Group
Stroke published August 20, 2009, doi:10.1161/STROKEAHA.109.558759
[Abstract]
- Articles
Do Endothelin-Receptor Antagonists Prevent Delayed Neurological Deficits and Poor Outcomes After Aneurysmal Subarachnoid Hemorrhage? A Meta-Analysis
- Andreas Kramer and Jeffrey Fletcher
Stroke published August 13, 2009, doi:10.1161/STROKEAHA.109.560243
[Abstract]
- Articles
Reliability of the Modified Rankin Scale. A Systematic Review
- Terence J. Quinn, Jesse Dawson, Matthew R. Walters, and Kennedy R. Lees
Stroke published August 13, 2009, doi:10.1161/STROKEAHA.109.557256
[Abstract]
|
|
